A Sensitive Assay for Virus Discovery in Respiratory Clinical Samples

Autor: Marja E. Jakobs, Martijn D. B. van de Garde, Herman Goossens, Michel de Vries, Frank E. J. Coenjaerts, Christine Lammens, Martin Deijs, Richard Molenkamp, Barbera D. C. van Schaik, Loes C. M. Jachimowski, Maarten F. Jebbink, Margareta Ieven, Marta Canuti, Lia van der Hoek, F.R. Leus, Frank Baas, Nuno R. Faria, Sylvie M. Koekkoek, Angela C. M. Luyf, Eric C. J. Claas
Přispěvatelé: Faculteit der Geneeskunde, Medical Microbiology and Infection Prevention, AII - Amsterdam institute for Infection and Immunity, ACS - Amsterdam Cardiovascular Sciences, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, ANS - Amsterdam Neuroscience, CCA -Cancer Center Amsterdam, Epidemiology and Data Science, Other departments, Human Genetics, Neurology, Genome Analysis
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Viral Diseases
Pulmonology
Gene Identification and Analysis
Common Cold
lcsh:Medicine
Polymerase Chain Reaction
Biochemistry
law.invention
DNA amplification
law
lcsh:Science
Respiratory Tract Infections
Polymerase chain reaction
0303 health sciences
Multidisciplinary
High-Throughput Nucleotide Sequencing
Viral Load
Clinical Laboratory Sciences
3. Good health
Nucleic acids
Lower Respiratory Tract Infections
Infectious Diseases
Viruses
Medicine
Research Article
Test Evaluation
DNA
Complementary

Diagnostic Techniques
Respiratory System

Biology
Sensitivity and Specificity
Microbiology
DNA sequencing
Virus
Molecular Genetics
03 medical and health sciences
Diagnostic Medicine
Virology
Complementary DNA
Genetics
030304 developmental biology
SARS
030306 microbiology
infections community children disease identification coronavirus pneumonia diagnosis etiology pcr
lcsh:R
RNA
DNA
Ribosomal RNA
Molecular biology
Reverse transcriptase
Viral Disease Diagnosis
Restriction enzyme
Viral Pneumonia
RNA
Ribosomal

DNA
Viral

Respiratory Infections
lcsh:Q
Human medicine
Zdroj: PLoS ONE, 6(1):e16118. Public Library of Science
PLoS ONE
PLoS ONE, 6(1)
PLoS ONE; Vol 6
PLoS ONE, Vol 6, Iss 1, p e16118 (2011)
PLoS ONE, 6(1). Public Library of Science
ISSN: 1932-6203
Popis: In 540% of respiratory infections in children, the diagnostics remain negative, suggesting that the patients might be infected with a yet unknown pathogen. Virus discovery cDNA-AFLP (VIDISCA) is a virus discovery method based on recognition of restriction enzyme cleavage sites, ligation of adaptors and subsequent amplification by PCR. However, direct discovery of unknown pathogens in nasopharyngeal swabs is difficult due to the high concentration of ribosomal RNA (rRNA) that acts as competitor. In the current study we optimized VIDISCA by adjusting the reverse transcription enzymes and decreasing rRNA amplification in the reverse transcription, using hexamer oligonucleotides that do not anneal to rRNA. Residual cDNA synthesis on rRNA templates was further reduced with oligonucleotides that anneal to rRNA but can not be extended due to 3′-dideoxy-C6-modification. With these modifications >90% reduction of rRNA amplification was established. Further improvement of the VIDISCA sensitivity was obtained by high throughput sequencing (VIDISCA-454). Eighteen nasopharyngeal swabs were analysed, all containing known respiratory viruses. We could identify the proper virus in the majority of samples tested (11/18). The median load in the VIDISCA-454 positive samples was 7.2 E5 viral genome copies/ml (ranging from 1.4 E37.7 E6). Our results show that optimization of VIDISCA and subsequent high-throughput-sequencing enhances sensitivity drastically and provides the opportunity to perform virus discovery directly in patient material.
Databáze: OpenAIRE